• Submitted by: admin
• Caribbean
• Destinations
• Education
• Havana
• history
• national
• Business and Economy
• Health and Medicine
• Science and Technology
• 12 / 09 / 2008

---

According to local health authorities, the facility can produce up to 100 million doses to meet the demand from Cuba and other countries.

In that regard, the plant will produce anti-meningococcal antigens, and will produce vaccines against typhoid fever and a multivalent vaccine against pneumococci.

The 1,000-square-meter plant was designed and built according to international standards in the pharmaceutical industry.

An important part of the plant is the specialized areas, also known as "clean rooms", where specific tasks in the production process are carried out.

(DTCuba)